e-Drug3D 1056 |
DIRITHROMYCIN DISCONTINUED
|
cas 62013-04-1 |
CLASS ANTIINFECTIVES |
ROUTE (list) ORAL |
ATC code |
PK parameters |
Target TARGET RIBOSOME |
DrugCentral Unknown |
Download SDF file | (1S,2R,4R,5R,6S,7S,8R,11R,12R,15R,17S)-5-[(2S,3R,4S,6R)-4-dimethylamino-3-hydroxy-6-methyloxan-2-yl]oxy-11-ethyl-4,12-dihydroxy-7-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-15-(2-methoxyethoxymethyl)-2,4,6,8,12,17-hexamethyl-10,14-dioxa-16-azabicyclo[11.3.1]heptadecan-9-one Formula: Calculated chemical properties: MW 835.06 NB_atoms 58 XLogP 2.20 PSA 147.944 NB_HD 5 NB_HA 16 fsp3 0.98 Lipinski(0=no;1=yes) 0 |
FDA NDA 050678 (pdf not found) INN (DIRITHROMYCIN) DYNABAC (LILLY RES LABS) APPROVAL= AP YEAR= 1995 NEWMOLECULARENTITY DISCONTINUED |
Other links: |